Medical Research Finder

Start
Features
Free trial / FAQ

Researchers
Physicians
Pharmacists
Ecotrophologists
Product Managers
in Health Industries

Loading…

© 2026 meRfi®

Medical Research Finder

Legal Notice
Privacy
Terms of Use

meRfi® Microbiome - The Digital Gut Microbiome Reference (incl. AI Chat)
Prebiotics, Probiotics, FMT / Manipulators of the Intestinal Microbiota

AuthorsReferences (Sources)

AuthorsReferences (Sources)

meRfi® AI Chat

Clotrimazole + Lacticaseibacillus rhamnosus + Lactobacillus acidophilus + Lactoferrin & Vulvovaginal candidiasis (VVC) / Vaginal yeast infection

Welcome to meRfi Microbiome!

Please register to continue your trial period!

meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.

Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.

Start your free trial and transform your understanding of the gut microbiota today!

Register for a free trial

Navigation

Contents

Randomized clinical trials (RCTs)

XXX - Clotrimazole + Lacticaseibacillus rhamnosus HN001 + Lactobacillus acidophilus GLA-14 + Lactoferrin vs Clotrimazole & Vulvovaginal candidiasis (VVC) / Vaginal yeast infection
revealed that the combination Clotrimazole + Lacticaseibacillus rhamnosus HN001 + Lactobacillus acidophilus GLA-14 + Lactoferrin is a safe and effective supplementary method for alleviating symptoms and reducing the recurrence of RVVC (1)

References

(1) Russo et al. 2019 Mycoses 62(4): 328-335

see also:
Vulvovaginal candidiasis (VVC) / Vaginal yeast infection & Drugs/Treatments

…

References (Sources)

Randomised clinical trial in women with Recurrent Vulvovaginal Candidiasis: Efficacy of probiotics and lactoferrin as maintenance treatment
Russo et al. 2019 Mycoses 62(4): 328-335

AI Chat

7/1/2026

Chat with our artificial intelligence: